首页|Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

扫码查看
原文链接
  • 万方数据
In the last decade,messenger ribonucleic acid(mRNA)-based drugs have gained great interest in both immunotherapy and non-immunogenic applications.This surge in interest can be largely attributed to the demonstration of distinct advantages offered by various mRNA molecules,alongside the rapid advancements in nucleic acid delivery systems.It is noteworthy that the immunogenicity of mRNA drugs presents a double-edged sword.In the context of immunotherapy,extra supplementation of adjuvant is generally required for induction of robust immune responses.Conversely,in non-immunotherapeutic scenarios,immune activation is unwanted considering the host tolerability and high expression demand for mRNA-encoded functional proteins.Herein,mainly focused on the linear non-replicating mRNA,we overview the preclinical and clinical progress and prospects of mRNA medicines encompassing vaccines and other therapeutics.We also highlight the importance of focusing on the host-specific variations,including age,gender,pathological condition,and concurrent medication of individual patient,for maximized efficacy and safety upon mRNA administration.Furthermore,we deliberate on the potential challenges that mRNA drugs may encounter in the realm of disease treatment,the current endeavors of improvement,as well as the application prospects for future advancements.Overall,this review aims to present a comprehensive understanding of mRNA-based therapies while illuminating the prospective development and clinical application of mRNA drugs.

Yingying Shi、Meixing Shi、Yi Wang、Jian You

展开 >

College of Pharmaceutical Sciences,Zhejiang University,866 Yuhangtang Road,Hangzhou,Zhejiang,P.R.China

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,79 Qingchun Road,Shangcheng District,Hangzhou,Zhejiang,P.R.China

The First Affiliated Hospital,College of Medicine,Zhejiang University,79 QingChun Road,Hangzhou,Zhejiang,P.R.China

Jinhua Institute of Zhejiang University,498 Yiwu Street,Jinhua,Zhejiang,P.R.China

展开 >

2024

10.1038/s41392-024-02002-z

信号转导与靶向治疗(英文)

信号转导与靶向治疗(英文)

CSTPCD
ISSN：
年,卷(期)：2024.9(12)